Selected research
Industry Research
Loratadine API Industry Research Report 2026
Market perspective
The global Loratadine API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Loratadine API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Loratadine API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Loratadine API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Loratadine API include Shenzhen Salubris Pharmaceuticals, Shenzhen Haibin Pharmaceutical, Merck Group, Mylan, Shaanxi Hanjiang, Changzhou Yabang, Changzhou Fangyuan Pharmaceutical, Vasudha Pharma Chem and Ultratech India Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Loratadine API market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Loratadine API Market by Company
Shenzhen Salubris Pharmaceuticals
Shenzhen Haibin Pharmaceutical
Merck Group
Mylan
Shaanxi Hanjiang
Changzhou Yabang
Changzhou Fangyuan Pharmaceutical
Vasudha Pharma Chem
Ultratech India Limited
Morepen
Inke, S.A.
Hetero Drugs Ltd
Cadila Pharmaceuticals
Argon Drugs
Loratadine API Segment by Type
Pharmaceutical Standards Grade
EP Standards Grade
USP Standards Grade
Others
Loratadine API Segment by Application
Loratadine Syrup
Loratadine Tablet
Loratadine Capsules
Dry Suspension
Others
Loratadine API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loratadine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Loratadine API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loratadine API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Loratadine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Loratadine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Loratadine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pharmaceutical Standards Grade
- EP Standards Grade
- USP Standards Grade
- Others
Applications
- Loratadine Syrup
- Loratadine Tablet
- Loratadine Capsules
- Dry Suspension
- Others
Companies covered
- Shenzhen Salubris Pharmaceuticals
- Shenzhen Haibin Pharmaceutical
- Merck Group
- Mylan
- Shaanxi Hanjiang
- Changzhou Yabang
- Changzhou Fangyuan Pharmaceutical
- Vasudha Pharma Chem
- Ultratech India Limited
- Morepen
- Inke, S.A.
- Hetero Drugs Ltd
- Cadila Pharmaceuticals
- Argon Drugs
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Loratadine API Market Size (2021-2032)
- 2.2.2 Global Loratadine API Sales (2021-2032)
- 2.2.3 Global Loratadine API Market Average Price (2021-2032)
- 2.3 Loratadine API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pharmaceutical Standards Grade
- 2.3.3 EP Standards Grade
- 2.3.4 USP Standards Grade
- 2.3.5 Others
- 2.4 Loratadine API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Loratadine Syrup
- 2.4.3 Loratadine Tablet
- 2.4.4 Loratadine Capsules
- 2.4.5 Dry Suspension
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Loratadine API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Loratadine API Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global Loratadine API Revenue of Manufacturers (2021-2026)
- 3.4 Global Loratadine API Average Price by Manufacturers (2021-2026)
- 3.5 Global Loratadine API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Loratadine API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Loratadine API, Product Type & Application
- 3.8 Global Manufacturers of Loratadine API, Established Date
- 3.9 Global Loratadine API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Shenzhen Salubris Pharmaceuticals
- 4.1.1 Shenzhen Salubris Pharmaceuticals Company Information
- 4.1.2 Shenzhen Salubris Pharmaceuticals Business Overview
- 4.1.3 Shenzhen Salubris Pharmaceuticals Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Shenzhen Salubris Pharmaceuticals Loratadine API Product Portfolio
- 4.1.5 Shenzhen Salubris Pharmaceuticals Recent Developments
- 4.2 Shenzhen Haibin Pharmaceutical
- 4.2.1 Shenzhen Haibin Pharmaceutical Company Information
- 4.2.2 Shenzhen Haibin Pharmaceutical Business Overview
- 4.2.3 Shenzhen Haibin Pharmaceutical Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shenzhen Haibin Pharmaceutical Loratadine API Product Portfolio
- 4.2.5 Shenzhen Haibin Pharmaceutical Recent Developments
- 4.3 Merck Group
- 4.3.1 Merck Group Company Information
- 4.3.2 Merck Group Business Overview
- 4.3.3 Merck Group Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Group Loratadine API Product Portfolio
- 4.3.5 Merck Group Recent Developments
- 4.4 Mylan
- 4.4.1 Mylan Company Information
- 4.4.2 Mylan Business Overview
- 4.4.3 Mylan Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mylan Loratadine API Product Portfolio
- 4.4.5 Mylan Recent Developments
- 4.5 Shaanxi Hanjiang
- 4.5.1 Shaanxi Hanjiang Company Information
- 4.5.2 Shaanxi Hanjiang Business Overview
- 4.5.3 Shaanxi Hanjiang Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shaanxi Hanjiang Loratadine API Product Portfolio
- 4.5.5 Shaanxi Hanjiang Recent Developments
- 4.6 Changzhou Yabang
- 4.6.1 Changzhou Yabang Company Information
- 4.6.2 Changzhou Yabang Business Overview
- 4.6.3 Changzhou Yabang Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Changzhou Yabang Loratadine API Product Portfolio
- 4.6.5 Changzhou Yabang Recent Developments
- 4.7 Changzhou Fangyuan Pharmaceutical
- 4.7.1 Changzhou Fangyuan Pharmaceutical Company Information
- 4.7.2 Changzhou Fangyuan Pharmaceutical Business Overview
- 4.7.3 Changzhou Fangyuan Pharmaceutical Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Changzhou Fangyuan Pharmaceutical Loratadine API Product Portfolio
- 4.7.5 Changzhou Fangyuan Pharmaceutical Recent Developments
- 4.8 Vasudha Pharma Chem
- 4.8.1 Vasudha Pharma Chem Company Information
- 4.8.2 Vasudha Pharma Chem Business Overview
- 4.8.3 Vasudha Pharma Chem Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Vasudha Pharma Chem Loratadine API Product Portfolio
- 4.8.5 Vasudha Pharma Chem Recent Developments
- 4.9 Ultratech India Limited
- 4.9.1 Ultratech India Limited Company Information
- 4.9.2 Ultratech India Limited Business Overview
- 4.9.3 Ultratech India Limited Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Ultratech India Limited Loratadine API Product Portfolio
- 4.9.5 Ultratech India Limited Recent Developments
- 4.10 Morepen
- 4.10.1 Morepen Company Information
- 4.10.2 Morepen Business Overview
- 4.10.3 Morepen Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Morepen Loratadine API Product Portfolio
- 4.10.5 Morepen Recent Developments
- 4.11 Inke, S.A.
- 4.11.1 Inke, S.A. Company Information
- 4.11.2 Inke, S.A. Business Overview
- 4.11.3 Inke, S.A. Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Inke, S.A. Loratadine API Product Portfolio
- 4.11.5 Inke, S.A. Recent Developments
- 4.12 Hetero Drugs Ltd
- 4.12.1 Hetero Drugs Ltd Company Information
- 4.12.2 Hetero Drugs Ltd Business Overview
- 4.12.3 Hetero Drugs Ltd Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hetero Drugs Ltd Loratadine API Product Portfolio
- 4.12.5 Hetero Drugs Ltd Recent Developments
- 4.13 Cadila Pharmaceuticals
- 4.13.1 Cadila Pharmaceuticals Company Information
- 4.13.2 Cadila Pharmaceuticals Business Overview
- 4.13.3 Cadila Pharmaceuticals Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Cadila Pharmaceuticals Loratadine API Product Portfolio
- 4.13.5 Cadila Pharmaceuticals Recent Developments
- 4.14 Argon Drugs
- 4.14.1 Argon Drugs Company Information
- 4.14.2 Argon Drugs Business Overview
- 4.14.3 Argon Drugs Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Argon Drugs Loratadine API Product Portfolio
- 4.14.5 Argon Drugs Recent Developments
5 Global Loratadine API Market Scenario by Region
- 5.1 Global Loratadine API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Loratadine API Sales by Region: 2021-2032
- 5.2.1 Global Loratadine API Sales by Region: 2021-2026
- 5.2.2 Global Loratadine API Sales by Region: 2027-2032
- 5.3 Global Loratadine API Revenue by Region: 2021-2032
- 5.3.1 Global Loratadine API Revenue by Region: 2021-2026
- 5.3.2 Global Loratadine API Revenue by Region: 2027-2032
- 5.4 North America Loratadine API Market Facts & Figures by Country
- 5.4.1 North America Loratadine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Loratadine API Sales by Country (2021-2032)
- 5.4.3 North America Loratadine API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Loratadine API Market Facts & Figures by Country
- 5.5.1 Europe Loratadine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Loratadine API Sales by Country (2021-2032)
- 5.5.3 Europe Loratadine API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Loratadine API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Loratadine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Loratadine API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Loratadine API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Loratadine API Market Facts & Figures by Country
- 5.7.1 South America Loratadine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Loratadine API Sales by Country (2021-2032)
- 5.7.3 South America Loratadine API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Loratadine API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Loratadine API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Loratadine API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Loratadine API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Loratadine API Sales by Type (2021-2032)
- 6.1.1 Global Loratadine API Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global Loratadine API Sales Market Share by Type (2021-2032)
- 6.2 Global Loratadine API Revenue by Type (2021-2032)
- 6.2.1 Global Loratadine API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Loratadine API Revenue Market Share by Type (2021-2032)
- 6.3 Global Loratadine API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Loratadine API Sales by Application (2021-2032)
- 7.1.1 Global Loratadine API Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global Loratadine API Sales Market Share by Application (2021-2032)
- 7.2 Global Loratadine API Revenue by Application (2021-2032)
- 7.2.1 Global Loratadine API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Loratadine API Revenue Market Share by Application (2021-2032)
- 7.3 Global Loratadine API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Loratadine API Value Chain Analysis
- 8.1.1 Loratadine API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Loratadine API Production Mode & Process
- 8.2 Loratadine API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Loratadine API Distributors
- 8.2.3 Loratadine API Customers
9 Global Loratadine API Analyzing Market Dynamics
- 9.1 Loratadine API Industry Trends
- 9.2 Loratadine API Industry Drivers
- 9.3 Loratadine API Industry Opportunities and Challenges
- 9.4 Loratadine API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst